Haleon plc Announces Purchase of 11,006,678 Ordinary Shares Under Buyback Programme
Haleon (LSE:HLN) Faces Weaker Returns, Does The Fair Value Case Still Hold?
Haleon (LSE:HLN) Stock Looks Reasonable Given Its Cash Flow Upside
Haleon: If Staples Hold Up, The Stock Should Outperform
Haleon (LSE:HLN) Stock Fair Value Falls After Guidance Cut And Mixed Analyst Revisions
Haleon plc Purchases 12,572,956 Ordinary Shares Under Buyback Programme
Does Reduced Growth Guidance Change The Bull Case For Haleon (LSE:HLN)?
Haleon margin reset and weak sales beyond oral care prompt Jefferies downgrade to 'hold'
Haleon faces calls for a reset as brokers question growth outlook
Haleon plc Announces Commencement of £500m Share Buyback Programme
Haleon Catches a Cold at the Worst Possible Time
ASAIY or HLN: Which Is the Better Value Stock Right Now?
Haleon plc (HLN) Q3 2026 Sales/Trading Call Transcript
What Haleon (HLN) Said on Its Q3 Earnings Call
Haleon Adjusts FY26 Organic Revenue Growth To ~2.5%, High-Single-Digit Adjusted Operating Profit Growth At Constant Currency, Net Interest Of ~£255 Million, Incorporating China Centrum OTC Product Classification Changes And Accelerated Brazil Go-To-Market Model Rollout
Consumer Healthcare Giant Haleon Plunges to 52-Week Low
Haleon Commences £500 Million Share Buyback Program
Haleon shares hit three-week low after growth downgrade, £500 million buyback
Haleon shares plunge 14% after £500 million buyback launch - UPDATE
Haleon CEO Says 70% Of Cold And Flu Business Is Outside U.S.; Season Start Not Yet Seen In International Markets, Slightly Down To Date; China Centrum OTC Issue Not Expected To Have Solution In 2027; Working To Mitigate By Making Portfolio Changes In China; Doesn't Believe Company Has Pricing Issue, We Have Pricing Elasticities
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.